Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3787 USD | -4.92% | -28.81% | +39.38% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 27.22M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -27M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.42
x | P/E ratio 2025 * |
-1.06
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.72% |
Latest transcript on Brainstorm Cell Therapeutics Inc.
1 day | -2.08% | ||
1 week | -27.03% | ||
Current month | +3.31% | ||
1 month | -43.42% | ||
3 months | +2.63% | ||
6 months | +128.07% | ||
Current year | +42.86% |
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 07-06-30 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 12-12-22 |
Chief Tech/Sci/R&D Officer | - | 22-05-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 00-09-21 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
Jacob Frenkel
CHM | Chairman | 81 | 20-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.3787 | -4.92% | 530 550 |
24-05-02 | 0.3983 | -8.33% | 1,347,981 |
24-05-01 | 0.4345 | +15.10% | 1,918,884 |
24-04-30 | 0.3775 | -30.04% | 1,736,018 |
24-04-29 | 0.5396 | +0.95% | 80,677 |
Delayed Quote Nasdaq, May 03, 2024 at 02:51 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.86% | 27.22M | |
+24.48% | 48.09B | |
+46.90% | 40.62B | |
-3.15% | 40.43B | |
-6.20% | 28.36B | |
+9.31% | 24.89B | |
-20.58% | 19.01B | |
+28.55% | 12.09B | |
+0.51% | 11.88B | |
-1.07% | 11.8B |
- Stock Market
- Equities
- BCLI Stock